Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF)

MLA

Dike B. Ojji, et al. “Bi Treatment with Hydralazine/Nitrates vs. Placebo in Africans Admitted with Acute HEart Failure (BA-HEF).” European Journal of Heart Failure, vol. 18, no. 10, Apr. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0bf9dca37b1091c962ef57cde09154db&authtype=sso&custid=ns315887.

APA

Dike B. Ojji, Charles Kouam Kouam, Bongani M. Mayosi, Karen Sliwa, Serigne Abdou Ba, Christopher L. Edwards, Olga Milo, Elijah Ogola, Charles Mondo, O.S. Ogah, Gad Cotter, Anastase Dzudie, Gerald Yonga, Beth A. Davison, Albertino Damasceno, & Mahmoud U Sani. (2016). Bi treatment with hydralazine/nitrates vs. placebo in Africans admitted with acute HEart Failure (BA-HEF). European Journal of Heart Failure, 18(10).

Chicago

Dike B. Ojji, Charles Kouam Kouam, Bongani M. Mayosi, Karen Sliwa, Serigne Abdou Ba, Christopher L. Edwards, Olga Milo, et al. 2016. “Bi Treatment with Hydralazine/Nitrates vs. Placebo in Africans Admitted with Acute HEart Failure (BA-HEF).” European Journal of Heart Failure 18 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0bf9dca37b1091c962ef57cde09154db&authtype=sso&custid=ns315887.